{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:11:21Z","timestamp":1788448281284,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,31]],"date-time":"2021-01-31T00:00:00Z","timestamp":1612051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001697","name":"Keio Gijuku Daigaku","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001697","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.alit.2021.01.004","type":"journal-article","created":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T07:59:10Z","timestamp":1613894350000},"page":"335-342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with anticonvulsants in a Japanese population: Matched case\u2013control and cohort studies"],"prefix":"10.1016","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7147-0737","authenticated-orcid":false,"given":"Toshiki","family":"Fukasawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiko","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanae","family":"Tanemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Amagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6913-9930","authenticated-orcid":false,"given":"Hisashi","family":"Urushihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.alit.2021.01.004_bib1","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1097\/CCM.0b013e31821201ed","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review","volume":"39","author":"Gerull","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.alit.2021.01.004_bib2","first-page":"1637","article-title":"[Japanese clinical guidelines for Stevens-Johnson syndrome and toxic epidermal necrolysis]","volume":"126","author":"Japanese Dermatological Association","year":"2016","journal-title":"Nihon Hifuka Gakkai Zasshi [Jpn J Dermatol]"},{"key":"10.1016\/j.alit.2021.01.004_bib3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jdermsci.2020.09.009","article-title":"The nationwide epidemiological survey of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan, 2016-2018","volume":"100","author":"Sunaga","year":"2020","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.alit.2021.01.004_bib4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jaad.2006.04.048","article-title":"Toxic epidermal necrolysis","volume":"56","author":"Pereira","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.alit.2021.01.004_bib5","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.alit.2021.01.004_bib6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study","volume":"128","author":"Mockenhaupt","year":"2008","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2021.01.004_bib7","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1111\/epi.13925","article-title":"The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugs","volume":"58","author":"Frey","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.alit.2021.01.004_bib8","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/all.14174","article-title":"Genetic variants associated with T cell-mediated cutaneous adverse drug reactions: a PRISMA-compliant systematic review-An EAACI position paper","volume":"75","author":"Oussalah","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2021.01.004_bib9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/cpt.1071","article-title":"The medication risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in Asians: the major drug causality and comparison with the US FDA label","volume":"105","author":"Wang","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.alit.2021.01.004_bib10","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.jaip.2020.09.011","article-title":"A\u00a0nationwide study of severe cutaneous adverse reactions based on the multicenter registry in Korea","volume":"9","author":"Kang","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2021.01.004_bib11","author":"The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use"},{"key":"10.1016\/j.alit.2021.01.004_bib12","doi-asserted-by":"crossref","first-page":"e0165933","DOI":"10.1371\/journal.pone.0165933","article-title":"Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis: a nationwide population-based study using national health insurance database in Korea","volume":"11","author":"Yang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.alit.2021.01.004_bib13","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/1346-8138.14528","article-title":"Incidence of Stevens-Johnson syndrome following combination drug use of allopurinol, carbamazepine and phenytoin in Taiwan: a case-control study","volume":"45","author":"Syu","year":"2018","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.alit.2021.01.004_bib16","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/pds.3276","article-title":"Validation of a claims-based diagnostic code for Stevens-Johnson syndrome in a commercially insured population","volume":"21","author":"Eisenberg","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.alit.2021.01.004_bib17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.alit.2019.06.006","article-title":"Identifying SJS\/TEN using ICD-9-CM coding - real or just fantasy?","volume":"69","author":"Carneiro-Le\u00e3o","year":"2020","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2021.01.004_bib18","doi-asserted-by":"crossref","first-page":"e0221130","DOI":"10.1371\/journal.pone.0221130","article-title":"Development of an electronic medical record-based algorithm to identify patients with Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan","volume":"14","author":"Fukasawa","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.alit.2021.01.004_bib19","author":"Pharmacoepidemiology and Database Taskforce"},{"key":"10.1016\/j.alit.2021.01.004_bib20","first-page":"413","article-title":"Development of a database of health insurance claims: standardization of disease classifications and anonymous record linkage","volume":"20","author":"Kimura","year":"2010","journal-title":"J\u00a0Epidemiol"},{"key":"10.1016\/j.alit.2021.01.004_bib21","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.atherosclerosis.2018.03.023","article-title":"Treatment patterns in hyperlipidaemia patients based on administrative claim databases in Japan","volume":"272","author":"Wake","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.alit.2021.01.004_bib22","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1186\/s12879-019-4186-x","article-title":"Influenza vaccination effectiveness for people aged under 65 years in Japan, 2013\/2014 season: application of a doubly robust method to a large-scale, real-world dataset","volume":"19","author":"Shibata","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.alit.2021.01.004_bib23","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1177\/2168479016679865","article-title":"Risk of acute asthma attacks associated with nonsteroidal anti-inflammatory drugs: a self-controlled case series","volume":"51","author":"Takeuchi","year":"2017","journal-title":"Ther Innov Regul Sci"},{"key":"10.1016\/j.alit.2021.01.004_bib24","author":"Medical Information System Development Center"},{"key":"10.1016\/j.alit.2021.01.004_bib28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2009.252","article-title":"ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis","volume":"88","author":"Sassolas","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.alit.2021.01.004_bib29","series-title":"Modern Epidemiology","first-page":"111","article-title":"Case-control studies","author":"Rothman","year":"2008"},{"key":"10.1016\/j.alit.2021.01.004_bib30","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2332\/allergolint.11-OA-0309","article-title":"Statistical analysis of Stevens-Johnson syndrome caused by Mycoplasma pneumonia infection in Japan","volume":"60","author":"Kunimi","year":"2011","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2021.01.004_bib31","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2165\/00002018-200225130-00006","article-title":"Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experience","volume":"25","author":"Forman","year":"2002","journal-title":"Drug Saf"},{"key":"10.1016\/j.alit.2021.01.004_bib32","first-page":"269","article-title":"Toxic epidermal necrolysis and Steven-Johnson syndrome in oncologic patients","volume":"11","author":"Gravante","year":"2007","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.alit.2021.01.004_bib33","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1067\/mjd.2003.107","article-title":"Lupus-associated toxic epidermal necrolysis: a novel manifestation of lupus?","volume":"48","author":"Mandelcorn","year":"2003","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.alit.2021.01.004_bib34","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2133.2011.10705.x","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with lupus erythematosus: a descriptive study of 17 cases from a national registry and review of the literature","volume":"166","author":"Ziemer","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.alit.2021.01.004_bib35","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1002\/sim.2687","article-title":"A\u00a0comparative investigation of methods for logistic regression with separated or nearly separated data","volume":"25","author":"Heinze","year":"2006","journal-title":"Stat Med"},{"key":"10.1016\/j.alit.2021.01.004_bib36","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1002\/sim.739","article-title":"Computational tools for exact conditional logistic regression","volume":"20","author":"Corcoran","year":"2006","journal-title":"Stat Med"},{"key":"10.1016\/j.alit.2021.01.004_bib37","doi-asserted-by":"crossref","first-page":"i1981","DOI":"10.1136\/bmj.i1981","article-title":"Sparse data bias: a problem hiding in plain sight","volume":"352","author":"Greenland","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.alit.2021.01.004_bib38","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/ije\/dys213","article-title":"Bayesian regression in SAS software","volume":"42","author":"Sullivan","year":"2013","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.alit.2021.01.004_bib39","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/sim.3794","article-title":"Bias-reduced and separation-proof conditional logistic regression with small or sparse data sets","volume":"29","author":"Heinze","year":"2010","journal-title":"Stat Med"},{"key":"10.1016\/j.alit.2021.01.004_bib40","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/epi.14063","article-title":"Response: the risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugs: comment on data sparsity","volume":"59","author":"Frey","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.alit.2021.01.004_bib41","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/oxfordjournals.aje.a010240","article-title":"Problems due to small samples and sparse data in conditional logistic regression analysis","volume":"151","author":"Greenland","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.alit.2021.01.004_bib42","author":"Heinze"},{"key":"10.1016\/j.alit.2021.01.004_bib43","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s40262-013-0087-0","article-title":"Drug interactions with the newer antiepileptic drugs (AEDs)-part 1: pharmacokinetic and pharmacodynamic interactions between AEDs","volume":"52","author":"Patsalos","year":"2013","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.alit.2021.01.004_bib44","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pharmthera.2004.10.013","article-title":"UDP-glucuronosyltransferases and clinical drug-drug interactions","volume":"106","author":"Kiang","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.alit.2021.01.004_bib45","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1212\/01.wnl.0000334295.50403.4c","article-title":"Cross-sensitivity of skin rashes with antiepileptic drug use","volume":"71","author":"Hirsch","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.alit.2021.01.004_bib46","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0920-1211(01)00309-6","article-title":"Carbamazepine toxicity during combination therapy with levetiracetam: a pharmacodynamic interaction","volume":"48","author":"Sisodiya","year":"2002","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.alit.2021.01.004_bib47","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2165\/00002018-199921060-00005","article-title":"Anticonvulsant hypersensitivity syndrome: incidence, prevention and management","volume":"21","author":"Knowles","year":"1999","journal-title":"Drug Saf"},{"key":"10.1016\/j.alit.2021.01.004_bib48","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.eplepsyres.2011.02.005","article-title":"Influence of chemical structure on skin reactions induced by antiepileptic drugs\u2014the role of the aromatic ring","volume":"94","author":"Wang","year":"2011","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.alit.2021.01.004_bib49","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1212\/01.wnl.0000261917.83337.db","article-title":"Comparison and predictors of rash associated with 15 antiepileptic drugs","volume":"68","author":"Arif","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.alit.2021.01.004_bib50","unstructured":"Kurosawa M, Sueki H, Sunaga Y, Morita E, Kokaze A, Nihara H, et al. [Estimated number of patients of Stevens-Johnson syndrome and toxic epidermal necrolysis: a national epidemiological survey]. Poster presented at: The 30th Annual Scientific Meeting of the Japan Epidemiological Association, 20\u201322 February 2020, Kyoto, Japan (in Japanese)."},{"key":"10.1016\/j.alit.2021.01.004_bib51","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ophtha.2008.12.048","article-title":"Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications","volume":"116","author":"Sotozono","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.alit.2021.01.004_bib52","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.2105\/AJPH.2012.300995","article-title":"Effects of disease misclassification on exposure\u2013disease association","volume":"103","author":"Chen","year":"2013","journal-title":"Am J Public Health"},{"key":"10.1016\/j.alit.2021.01.004_bib53","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2165\/11593240-000000000-00000","article-title":"Incidence of toxic epidermal necrolysis and Stevens-Johnson Syndrome in an HIV cohort: an observational, retrospective case series study","volume":"13","author":"Mittmann","year":"2012","journal-title":"Am J Clin Dermatol"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893021000071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893021000071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:11:07Z","timestamp":1761156667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1323893021000071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1323893021000071"],"URL":"https:\/\/doi.org\/10.1016\/j.alit.2021.01.004","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with anticonvulsants in a Japanese population: Matched case\u2013control and cohort studies","name":"articletitle","label":"Article Title"},{"value":"Allergology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alit.2021.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Japanese Society of Allergology. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}